Filter
1778
Filtered Results: 1778
Text search:
molecular
Featured
Recommendations
205
New Publications
331
Language
Document type
No document type
780
Guidelines
394
Studies & Reports
317
Manuals
103
Strategic & Response Plan
76
Fact sheets
53
Training Material
19
Situation Updates
17
Resource Platforms
9
Infographics
7
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
70
Global
62
Brazil
61
Western and Central Europe
60
Africa
39
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Ethiopia
22
Tanzania
22
Peru
22
Argentina
20
West and Central Africa
20
Venezuela
20
Russia
18
East and Southern Africa
17
El Salvador
16
Paraguay
15
Uganda
14
Mozambique
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Senegal
11
Philippines
11
Rwanda
11
Nepal
10
Angola
10
Asia
10
Congo, Democratic Republic of
9
Zambia
9
Ukraine
9
Ecuador
9
Chile
9
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Haiti
4
Pakistan
4
Italy
4
Vietnam
4
France
4
Guinea
3
Burkina Faso
3
Lebanon
3
Cambodia
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Chad
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Morocco
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Switzerland
1
Cuba
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Palestine
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
615
Clinical Guidelines
223
Public Health
76
Pharmacy & Technologies
65
Key Resources
29
Women & Child Health
23
Capacity Building
6
Toolboxes
TB
389
COVID-19
279
AMR
113
NTDs
111
HIV
86
Rapid Response
78
Mental Health
78
Ebola
46
Planetary Health
46
Zika
33
Pharmacy
31
NCDs
27
Refugee
21
Polio
14
Caregiver
14
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Los coronavirus son un grupo de virus ARN altamente diversos de la familia Coronaviridae que se dividen en
4 géneros: alfa, beta, gamma y delta, y que causan enfermedades de leves a graves en humanos y animales
(1-3). Existen coronavirus humanos endémicos como los alfacoronavirus 229E y NL63 y l...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Revised and expanded version of the Guidelines
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
